BENF Beneficient trounces first quarter 2026 loss estimates shares rise more than 7 percent today Astec ASTE Top Gainer Astec posts 252 EPS beat topping consensus analyst estimates WHWK Whitehawk Therapeutics falls 336 as Q4 2025 EPS misses estimates by a wide 1164 percent margin